Development	development	O	O	O	O
of	of	O	O	O	O
isoproterenol-induced	isoproterenol-induced	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
hypertrophy	hypertrophy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
hypertrophy	hypertrophy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
adult	adult	O	O	O	O
female	female	O	O	O	O
Wistar	wistar	O	O	O	O
rats	rats	O	O	O	O
following	following	O	O	O	O
daily	daily	O	O	O	O
subcutaneous	subcutaneous	O	O	O	O
injections	injections	O	O	O	O
of	of	O	O	O	O
isoproterenol	isoproterenol	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
ISO	iso	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
(	(	O	O	O	O
0.3	0.3	O	O	O	O
mg/kg	mg/kg	O	O	O	O
body	body	O	DISEASE	OTHERS	I
weight	weight	O	DISEASE	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
time	time	O	O	O	O
course	course	O	O	O	O
was	was	O	O	O	O
established	established	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
tissue	tissue	O	O	O	O
mass	mass	O	O	O	O
,	,	O	O	O	O
RNA	rna	O	O	O	O
and	and	O	O	O	O
DNA	dna	O	O	O	O
content	content	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
hydroxyproline	hydroxyproline	O	O	OTHERS	I
content	content	O	O	O	O
.	.	O	O	O	O

Heart	heart	O	O	O	O
weight	weight	O	O	O	O
increased	increased	O	O	O	O
44	44	O	O	O	O
%	%	O	O	O	O
after	after	O	O	O	O
8	8	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
half	half	O	O	O	O
time	time	O	O	O	O
of	of	O	O	O	O
3.4	3.4	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

Ventricular	ventricular	O	O	O	O
RNA	rna	O	O	O	O
content	content	O	O	O	O
was	was	O	O	O	O
elevated	elevated	O	O	O	O
26	26	O	O	O	O
%	%	O	O	O	O
after	after	O	O	O	O
24	24	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
of	of	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
injection	injection	O	O	O	O
and	and	O	O	O	O
reached	reached	O	O	O	O
a	a	O	O	O	O
maximal	maximal	O	O	O	O
level	level	O	O	O	O
following	following	O	O	O	O
8	8	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
half	half	O	O	O	O
time	time	O	O	O	O
for	for	O	O	O	O
RNA	rna	O	O	O	O
accumulation	accumulation	O	O	O	O
was	was	O	O	O	O
2.0	2.0	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
total	total	O	O	O	O
content	content	O	O	O	O
of	of	O	O	O	O
hydroxyproline	hydroxyproline	O	O	OTHERS	I
remained	remained	O	O	O	O
stable	stable	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
2	2	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
but	but	O	O	O	O
increased	increased	O	O	O	O
46	46	O	O	O	O
%	%	O	O	O	O
after	after	O	O	O	O
4	4	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Ventricular	ventricular	O	O	O	O
DNA	dna	O	O	O	O
content	content	O	O	O	O
was	was	O	O	O	O
unchanged	unchanged	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
early	early	O	O	O	O
stage	stage	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
4	4	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
hypertrophic	hypertrophic	O	O	OTHERS	I
growth	growth	O	O	O	O
but	but	O	O	O	O
increased	increased	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
new	new	O	O	O	O
steady-state	steady-state	O	O	O	O
level	level	O	O	O	O
19	19	O	O	O	O
%	%	O	O	O	O
above	above	O	O	O	O
the	the	O	O	O	O
controls	controls	O	O	O	O
after	after	O	O	O	O
8	8	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Intraventricular	intraventricular	O	O	O	O
pressures	pressures	O	O	O	O
and	and	O	O	O	O
coronary	coronary	O	O	O	O
flow	flow	O	O	O	O
measures	measures	O	O	O	O
were	were	O	O	O	O
similar	similar	O	O	O	O
for	for	O	O	O	O
control	control	O	O	O	O
and	and	O	O	O	O
experimental	experimental	O	O	O	O
animals	animals	O	O	O	O
following	following	O	O	O	O
4	4	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
developed	developed	O	O	O	O
hypertrophy	hypertrophy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
dP/dt	dp/dt	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
ISO-treated	iso-treated	O	O	O	O
hearts	hearts	O	O	O	O
was	was	O	O	O	O
slightly	slightly	O	O	O	O
but	but	O	O	O	O
significantly	significantly	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
elevated	elevated	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
data	data	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
adaptive	adaptive	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
ISO	iso	CHEMICALS	O	OTHERS	I
shows	shows	O	O	O	O
an	an	O	O	O	O
early	early	O	O	O	O
hypertrophic	hypertrophic	O	O	OTHERS	I
phase	phase	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
4	4	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
characterized	characterized	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
substantial	substantial	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
RNA	rna	O	O	O	O
content	content	O	O	O	O
and	and	O	O	O	O
cardiac	cardiac	O	O	O	O
mass	mass	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
absence	absence	O	O	O	O
of	of	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
DNA	dna	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
prolonged	prolonged	O	O	O	O
stimulation	stimulation	O	O	O	O
(	(	O	O	O	O
8	8	O	O	O	O
-	-	O	O	O	O
12	12	O	O	O	O
days	days	O	O	O	O
)	)	O	O	O	O
appears	appears	O	O	O	O
to	to	O	O	O	O
represent	represent	O	O	O	O
a	a	O	O	O	O
complex	complex	O	O	O	O
integration	integration	O	O	O	O
of	of	O	O	O	O
both	both	O	O	O	O
cellular	cellular	O	O	O	O
hypertrophy	hypertrophy	O	DISEASE	OTHERS	I
and	and	O	O	O	O
hyperplasia	hyperplasia	O	O	OTHERS	I
within	within	O	O	O	O
the	the	O	O	O	O
heart	heart	O	O	O	O
.	.	O	O	O	O

